NADIA SUNDLASS: Open Payments
NPI 1144563925 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 73 payments from 12 companies in 2025. Trend: 2023 $3,326 · 2024 $761 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 57 | $569 |
| Galderma Laboratories, L.P. | 1 | $88 |
| PFIZER INC. | 4 | $70 |
| Amgen Inc. | 2 | $38 |
| Janssen Biotech, Inc. | 2 | $30 |
| Incyte Corporation | 1 | $24 |
| Journey Medical Corporation | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: RINVOQ, SKYRIZI, NEMLUVIO, CIBINQO, OTEZLA, TREMFYA, OPZELURA, COSENTYX.
Industry payments across PA — which companies pay providers there.
